Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Catawba Research has managed nearly 100 clinical trials across more than 30 indications since its founding in 2014. The company boasts over thirty regulatory approvals from agencies such as the FDA, Health Canada, and DCGI. It has a strong track record of meeting or exceeding trial timelines for sponsors—70% of partnered trials meet or exceed objectives compared to an industry average of just ~20% finishing on time. Its expertise spans dermatology and women’s health with recent growth into pulmonary/respiratory disease, autoimmune conditions, neurology/neuroscience/rare diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Catawba Research.